436 related articles for article (PubMed ID: 19195966)
1. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
Haas M
Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
3. Thin basement membrane nephropathy.
Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
5. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
[TBL] [Abstract][Full Text] [Related]
6. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
Chen Y; Colville D; Ierino F; Symons A; Savige J
Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
[TBL] [Abstract][Full Text] [Related]
7. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
8. Familial hematuria: A review.
Plevová P; Gut J; Janda J
Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
Hou P; Chen Y; Ding J; Li G; Zhang H
Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
[TBL] [Abstract][Full Text] [Related]
10. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
11. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome.
Vizjak A; Ferluga D
Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():323-6. PubMed ID: 20804103
[TBL] [Abstract][Full Text] [Related]
13. Morphological diagnosis of Alport syndrome and thin basement membrane nephropathy by low vacuum scanning electron microscopy.
Okada S; Inaga S; Kitamoto K; Kawaba Y; Nakane H; Naguro T; Kaidoh T; Kanzaki S
Biomed Res; 2014; 35(5):345-50. PubMed ID: 25355442
[TBL] [Abstract][Full Text] [Related]
14. The genetics of thin basement membrane nephropathy.
Rana K; Wang YY; Buzza M; Tonna S; Zhang KW; Lin T; Sin L; Padavarat S; Savige J
Semin Nephrol; 2005 May; 25(3):163-70. PubMed ID: 15880327
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
Beirowski B; Weber M; Gross O
J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
[TBL] [Abstract][Full Text] [Related]
16. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
17. Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes.
Li A; Gao EZ; Cui YX; Liu JH; Lv X; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
Cytogenet Genome Res; 2018; 154(1):30-36. PubMed ID: 29669314
[TBL] [Abstract][Full Text] [Related]
18. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
Voskarides K; Pierides A; Deltas C
Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
[TBL] [Abstract][Full Text] [Related]
19. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.
Imafuku A; Nozu K; Sawa N; Nakanishi K; Ubara Y
Clin Exp Nephrol; 2020 Aug; 24(8):651-656. PubMed ID: 32232700
[TBL] [Abstract][Full Text] [Related]
20. Pathologic glomerular characteristics and glomerular basement membrane alterations in biopsy-proven thin basement membrane nephropathy.
Kajimoto Y; Endo Y; Terasaki M; Kunugi S; Igarashi T; Mii A; Terasaki Y; Shimizu A
Clin Exp Nephrol; 2019 May; 23(5):638-649. PubMed ID: 30687875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
